| Address |
150-11 Akerley Boulevard Dartmouth, B3B 1V7 Canada |
|
| Address type | Registered Office Address | |
| Address province | Nova Scotia |
| Corporation ID | 9822305 | |
| Business number | 761868496 | |
| Status | Active - Dissolution Pending (Non-compliance) | |
| ACT | Canada Business Corporations Act | |
| Status details | Active - Dissolution Pending (non-compliance) | |
| Anniversary date | 07/07/2016 | |
| Last annual filing | 2024 | |
| Data verified | 10/31/2026 |
Location: Statistics Canada, Open Database of Addresses (Open Government Licence – Canada).
| Name | Effective date | Type | Current |
|---|---|---|---|
| 9822305 Canada Inc. | 07/07/2016 | Corporate Name | |
| AXEM NEUROTECHNOLOGY INC. | 04/07/2017 | Corporate Name | true |
last updated: 2026-10-30
15 federal grants and contributions between 2018 and 2023 with a total value of $1,756,568. The 10 most recent agreements are listed below.
| Start date | Department and program | Value |
|---|---|---|
| 06/01/2023 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Commercialization preparation Axem Neurotechnology is preparing to go to market with a digital health service facilitating at-home stroke recovery. The current project will enable Axem to enhance its in-house manufacturing capacities, refine its device to enable a more scalable business model, and also improve its ability to... |
$200,000 |
| 05/22/2023 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) IP Assist: Intellectual Property Strategy Engagement The project will support development of intellectual property capacity within the firm. |
$15,000 |
| 12/07/2022 |
Atlantic Canada Opportunities Agency REGI - Business Scale-up and Productivity (contribution) 222002 Support for hiring a clinical data analyst and enhanced product development |
$100,000 |
| 06/01/2022 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Axem Home System Completion for Pivotal Clinical Trials Axem Neurotechnology is preparing to conduct pivotal clinical trials in 2023; this project entails work necessary for the use of those data for regulatory clearance (i.e., generating production equivalent version of the Axem Home headband), as well as work to de-risk those clinical trials with... |
$400,000 |
| 08/02/2021 |
National Research Council Canada Industrial Research Assistance Program – Contributions to Firms (contribution) Improve Mechanical/Thermal Design and Design Real-Time Neurofeedback This project involves improving the technical performance of its headband prototype, by both re-designing its mechanical parts such that they can be repeatedly made to specification, and re-designing its electrical and mechanical parts such that the headband has its external temperature reduced... |
$250,000 |
| 07/28/2021 |
Atlantic Canada Opportunities Agency REGI - Business Scale-up and Productivity (contribution) 218689 Conduct clinical trials on prototypes to demonstrate clinical value |
$100,000 |
| 12/20/2020 |
National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2.5 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support. |
$21,676 |
| 11/27/2020 |
Atlantic Canada Opportunities Agency REGI - Productivity and Business Skills (contribution) 217594 Engage consultants for two clinical studies |
$50,000 |
| 06/25/2020 |
Atlantic Canada Opportunities Agency REGI - Business Scale-up and Productivity (contribution) 215307 Provide assistance to mitigate impacts of Covid-19 |
$85,000 |
| 06/25/2020 |
National Research Council Canada Industrial Research Assistance Program – Innovation Assistance Program (contribution) Innovation Assistance Program – Round 2 The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small and medium-sized enterprises that are unable to access existing COVID-19 business support. |
$57,704 |
Source: Government of Canada, proactive disclosure of grants and contributions. Contains information licensed under the Open Government Licence – Canada.
| Date | Type | Section |
|---|---|---|
| 04/07/2017 | Amendment | 6 |
| 07/07/2016 | Incorporation |